Renal tubular cyst formation in newborn rats treated with p-cumylphenol

Journal of Toxicologic Pathology

Volumn 22, Issue 2, 2009, Pages 125-131

  Nakazawa, Tomomi ^a   Kasahara, Kenichiro ^a   Ikezaki, Shinichiro ^a   Yamaguchi, Yuko ^a   Edamoto, Hiroshi ^a   Nishimura, Nobuo ^a   Yahata, Megumi ^a   Tamura, Kazutoshi ^a   Kamata, Eiichi ^b   Ema, Makoto ^b   Hasegawa, Ryuichi ^b  

^a BoZo Research Center Inc   (Japan)

^b NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

Newborn rats; P cumylphenol; Polycystic kidney

Indexed keywords

CYCLINE; PHENOL DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; KIDNEY COLLECTING TUBULE; KIDNEY EPITHELIUM; KIDNEY MEDULLA; KIDNEY PAPILLA NECROSIS; KIDNEY POLYCYSTIC DISEASE; LYMPHOID CELL; MALE; NEPHROTOXICITY; NEWBORN; NONHUMAN; RAT;

EID: 70349694233     PISSN: 09149198     EISSN: None     Source Type: Journal    
DOI: 10.1293/tox.22.125     Document Type: Article

References (24)

1. Sweeney WE and Avner ED. Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD). Cell Tissue Res, 326: 671-685. 2006.
2. Torres VE, Harris PC, and Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 14: 1287-1301. 2007.
3. Hildebrandt F and Omram H. New insights: nephronophthisis-medullary cystic disease. Pediatr Nephrol. 16: 168-176. 2001.
4. Guay-Woodford LM. Murine models of polycystic kidney disease: molecular-and therapeutic insights. Am J Physiol Renal Physiol. 285: 1034-1049. 2003.
5. Jones TC, Hunt R, and King NW. Congenital and hereditary anomalies. In: The Urinary System, Veterinary Pathology 6th ed., Cann C, (ed), USA: Williams and Wilkins. 1113-1115, 1997.
6. Gardner Jr KD, Solomon S, Fitzgerrel WW, and Evan AP. Function and structure in the diphenylamine-exposed kidney. J Clin Invest. 57: 796-806. 1976.
7. Evan AP and Gardner Jr KD. Nephron obstruction in nordihydroguaiaretic acid-induced renal cystic disease. Kidney Int 1979; 15: 7-19.
8. Gardner Jr KD and Evan AP. Renal cystic disease induced y diphenylthiazole. Kidney Int. 24: 43-52. 1983.
9. Kovacs J, Zilahy M, Banyasz T, and Comba S. Evaluation of apoptosis and cell proliferation in experimentally induced renal cysm. Urol Res. 26: 411-416. 1998.
10. Tsumatani K, Nakagawa Y, Kitahori Y, Konishi N, Uemura H, Ozono S, Hirao Y, Okajima E, Hirao K, and Hiasa Y. Experimental model of renal tumors in polycystic kidneys: effects of long-term 2--amino-4,5-diphenylthiazole administration in rats treated with N-ethyl-N-hydrdxyethyl nitrosamine. Toxicol Pathol. 25: 363-371. 1997.
11. Latendresse JR, Newbold RR, Weis CC, and Delclos KB. Polycystic kidney disease induced in F (1) Sprague-Dawley rats fed para-nonylphenol in a soy-free casein-containing diet. Toxicol Sci. 62: 140-147. 2001.
12. Fukuda N, Ito Y, Yamaguchi M, Mitsumori K, Koizumi M, Hasegawa R, Kamata E, and Ema M. Unexpected nephrotoxicity induced by tetrabromobisphenol A in newborn rats. Toxicol Lett. 21: 145-155. 2004.
13. Concolino G, Lubrano C, Ombres M, Santonati A, Flammia GP, and Di Silverio F. Acquired cystic kidney disease: The hormonal hypothesis. Urology. 41: 170-175. 1993.
14. Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, Elia AE, Lu W, Brown EM, Quinn SJ, Ingber DE, and Zhou J. Polycystins 1 and 2 mediate, mechanosensation in the primary cilium of kidney cells. Nat Genet. 33: 129-137, 2003.
15. Yamaguchi T, Pelling JC, Ramaswamy NT, Eppler JW, Wallace DP, Nagao S, Rome LA, Sullivan LP, and Grantham JJ. cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int. 57: 1460-1471. 2000.
16. Nagao S, Yamaguchi T, Kusaka M, Maser RL, Takahashi H, Cowley BD, and Grantham JJ. Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease. Kidney Int. 63: 427-437. 2003.
17. Yamaguchi T, Nagau S, Wallace DP, Belibi FA, Cowley BD, Pelling JC, and Grantham JJ. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal-dominant polycystic; kidneys. Kidney Int. 63: 1983-1994. 2003.
18. Yamaguchi T, Wallace DP, Magenheimer BS, Hempson SJ, Grantham JJ, and Calvet JP. Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J Biol Chem. 279:40419-40430. 2004.
19. Hasegawa R, Hirata-Koizumi M, Takahashi M, Kamata E, and Ema M. Comparative susceptibility of newborn and young rats to six industrial chemicals. Congenit Anom. 45: 137-145. 2005.
20. Carone FA, Nakamura S, Punyarit P, Kanwar YS, and Nelson WJ. Sequential tubular cell and basement membrane changes in polycystic kidney disease. J Am Soc Nephrol. 3: 244-253. 1992.
21. Chevalier RL. Pathophysiology of obstructive nephropathy in the newborn. Semin Nephrol. 18: 585-593. 1998.
22. Chevalier RL, Goyal S, and Wolstenholme JT. Obstructive nephropathy in the neonate is attenuated by epidermal growth factor. Kidney Int. 54: 38-47. 1998.
23. Merlet-Benichou C, Gilbert T, Muffat-Joly M, Leliever-Pegorier M, and Leroy B. Intrauterine growth retardation leads to a permanent nephron deficit in the rat. Pediatr Nephrol. 8:175-180. 1994.
24. Chevalier RL. Growth factor and apoptosis in neonatal ureteral obstruction. J Am Soc Nephrol. 7: 1098-1105. 1996.